½ÃÀ庸°í¼­
»óǰÄÚµå
1605891

Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)

Artificial Tendons and Ligaments Market Size, Share, Trends, Industry Analysis Report: By Application, End Use, and Region - Market Forecast 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 1¾ï 245¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÃÖ¼Òħ½À ¼ö¼úÀÇ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ Àΰø°Ç ¹× ÀΰøÀδ뿡 ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼úÀº Àý°³Ã¢ÀÌ ÀÛ¾Æ Á¶Á÷ ¼Õ»óÀÌ Àû°í, ȯÀÚÀÇ È¸º¹ ½Ã°£À» ´ÜÃàÇϰí ÀÔ¿ø ±â°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¨¿°À̳ª ÈäÅÍ¿Í °°Àº ¼ö¼ú ÈÄ ÇÕº´ÁõÀÌ Àû±â ¶§¹®¿¡ ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. ȯÀÚ °á°úÀÇ °³¼±°ú Àüü ÀÇ·áºñ Àý°¨°ú ÇÔ²² Á¤Çü¿Ü°ú Ä¡·á¿¡¼­ ÃÖ¼Òħ½ÀÀû Á¢±Ù¹ýÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ¸é¼­ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ºÆ÷Ã÷ ÀÇÇп¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ºÆ÷Ã÷ ºÎ»ó Ä¡·á¿Í ÀçȰÀÇ ÀÌÁ¡À» ÀνÄÇÏ´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÷´Ü °üÀý ÀÓÇöõÆ® ¹× ÃÖ¼Òħ½À ¼ö¼ú ±â¼ú°ú °°Àº Á¤Çü¿Ü°úÀû ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÌÇØµµ°¡ ³ô¾ÆÁö¸é¼­ ¿îµ¿¼±¼ö¿Í Ȱµ¿ÀûÀÎ °³ÀεéÀÇ ºü¸¥ ȸº¹°ú È¿À²ÀûÀΠȰµ¿ Àç°³¸¦ µ½´Â ÷´Ü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¹¹æ ÀÇ·á¿Í ȸº¹ °á°ú °³¼±¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ Çõ½ÅÀûÀÎ Á¦Ç°À» äÅÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿ëµµº°·Î´Â ÁÖ·Î Àü¹æ½ÊÀÚÀδë(ACL) ¼Õ»ó ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ 2024³â ¹«¸­ ¼Õ»ó ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó 2024³â¿¡´Â º´¿ø¿¡¼­ ½ÃÇàµÇ´Â ÈûÁÙ ¼öº¹ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø ºÎ¹®ÀÌ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

2024³â À¯·´ÀÌ Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀ» µ¶Á¡Çߴµ¥, ÀÌ´Â ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ Á¸ÀçÇϰí Çõ½ÅÀûÀÎ Ä¡·á ¿É¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ³ôÀº ¼öÁØÀÇ ÀÇ·á ¼­ºñ½º ´öºÐÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ÀÎÇØ ½ºÆ÷Ã÷ Âü¿©°¡ Áõ°¡Çϰí ÀÌ¿¡ µû¶ó ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀåÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷À¸·Î´Â COUSIN SURGERY, Smith+Nephew, Zimmer Biomet, Xiros Ltd. (Neoligaments), Orthomed, Shanghai PINE&POWER Biotech, Arthrex Inc., Corin Group, Enovis Corporation (Mathys AG Bettlach), Stryker, and GROUP FH ORTHO µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ½ºÆ÷Ã÷ °ü·Ã »óÇØ »ç°Ç Áõ°¡
      • ÷´Ü Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ È¯ÀÚ ¼±È£
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • ÁÖ¿ä ½ÃÀåÀÇ °í¾×ÀÇ ¼ö¼ú ºñ¿ë°ú ºÒ¸®ÇÑ »óȯ ½Ã³ª¸®¿À
  • PESTEL ºÐ¼®
  • Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå ÃÖÁ¾ ¿ëµµ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¹«¸­ ºÎ»ó
  • ¾î±ú ºÎ»ó
  • ¹ß°ú ¹ß¸ñ ºÎ»ó
  • ±âŸ ¿ëµµ

Á¦6Àå Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø
  • ¿Ü·¡ ½Ã¼³

Á¦7Àå Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • Àΰø°Ç ¹× ÀΰøÀÎ´ë ½ÃÀå Æò°¡ : Áö¿ª, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : ¿ëµµº°, 2020-2034³â
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¹Ì±¹
      • ¹Ì±¹ : ¿ëµµº°, 2020-2034³â
      • ¹Ì±¹ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ij³ª´Ù
      • ij³ª´Ù : ¿ëµµº°, 2020-2034³â
      • ij³ª´Ù : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
  • À¯·´
    • À¯·´ : ¿ëµµº°, 2020-2034³â
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¿µ±¹
      • ¿µ±¹ : ¿ëµµº°, 2020-2034³â
      • ¿µ±¹ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ÇÁ¶û½º
      • ÇÁ¶û½º : ¿ëµµº°, 2020-2034³â
      • ÇÁ¶û½º : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • µ¶ÀÏ
      • µ¶ÀÏ : ¿ëµµº°, 2020-2034³â
      • µ¶ÀÏ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ÀÌÅ»¸®¾Æ
      • ÀÌÅ»¸®¾Æ : ¿ëµµº°, 2020-2034³â
      • ÀÌÅ»¸®¾Æ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ½ºÆäÀÎ
      • ½ºÆäÀÎ : ¿ëµµº°, 2020-2034³â
      • ½ºÆäÀÎ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ³×´ú¶õµå
      • ³×´ú¶õµå : ¿ëµµº°, 2020-2034³â
      • ³×´ú¶õµå : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ·¯½Ã¾Æ
      • ·¯½Ã¾Æ : ¿ëµµº°, 2020-2034³â
      • ·¯½Ã¾Æ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ±âŸ À¯·´
      • ±âŸ À¯·´ : ¿ëµµº°, 2020-2034³â
      • ±âŸ À¯·´ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Áß±¹
      • Áß±¹ : ¿ëµµº°, 2020-2034³â
      • Áß±¹ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Àεµ
      • Àεµ : ¿ëµµº°, 2020-2034³â
      • Àεµ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¸»·¹À̽þÆ
      • ¸»·¹ÀÌ½Ã¾Æ : ¿ëµµº°, 2020-2034³â
      • ¸»·¹ÀÌ½Ã¾Æ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ÀϺ»
      • ÀϺ» : ¿ëµµº°, 2020-2034³â
      • ÀϺ» : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Àεµ³×½Ã¾Æ
      • Àεµ³×½Ã¾Æ : ¿ëµµº°, 2020-2034³â
      • Àεµ³×½Ã¾Æ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Çѱ¹
      • Çѱ¹ : ¿ëµµº°, 2020-2034³â
      • Çѱ¹ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • È£ÁÖ
      • È£ÁÖ : ¿ëµµº°, 2020-2034³â
      • È£ÁÖ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
      • »ç¿ìµð¾Æ¶óºñ¾Æ : ¿ëµµº°, 2020-2034³â
      • »ç¿ìµð¾Æ¶óºñ¾Æ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • UAE : ¿ëµµº°, 2020-2034³â
      • UAE : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • À̽º¶ó¿¤
      • À̽º¶ó¿¤ : ¿ëµµº°, 2020-2034³â
      • À̽º¶ó¿¤ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : ¿ëµµº°, 2020-2034³â
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¸ß½ÃÄÚ
      • ¸ß½ÃÄÚ : ¿ëµµº°, 2020-2034³â
      • ¸ß½ÃÄÚ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ºê¶óÁú
      • ºê¶óÁú : ¿ëµµº°, 2020-2034³â
      • ºê¶óÁú : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¸£ÇîÆ¼³ª : ¿ëµµº°, 2020-2034³â
      • ¾Æ¸£ÇîÆ¼³ª : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â

Á¦8Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦9Àå ±â¾÷ °³¿ä

  • Arthrex Inc.
  • Corin Group
  • COUSIN SURGERY
  • Enovis Corporation(Mathys AG Bettlach)
  • GROUP FH ORTHO
  • Orthomed
  • Shanghai PINE&POWER Biotech
  • SMITH+NEPHEW
  • Stryker
  • Xiros Ltd.(Neoligaments)
  • ZIMMER BIOMET
ksm 24.12.27

The artificial tendons and ligaments market size is expected to reach USD 102.45 million by 2034, according to a new study by Polaris Market Research. The report "Artificial Tendon and Ligaments Market Size, Share, Trends, Industry Analysis Report: By Application, End Use (Hospitals and Outpatient Facilities), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing importance of minimally invasive surgeries is significantly driving the demand for artificial tendons and ligaments, as these procedures offer several advantages over traditional open surgeries. Minimally invasive techniques involve smaller incisions, which result in reduced tissue damage, leading to faster recovery times and shorter hospital stays for patients. Additionally, these methods are associated with fewer post-operative complications, such as infections and scarring, making them a preferred choice for both patients and healthcare providers. The combination of improved patient outcomes and lower overall healthcare costs is accelerating the adoption of minimally invasive approaches in orthopedic treatments, further boosting the market for artificial tendons and ligaments.

The increasing awareness about sports medicine is playing a crucial role in propelling the artificial tendon and ligament market growth as more people recognize the benefits of timely sports injury treatments and rehabilitation. Furthermore, the growing understanding of orthopedic solutions such as advanced joint implants and minimally invasive surgical techniques is driving demand for advanced medicine that helps athletes and active individuals recover quickly and resume their activities efficiently. The emphasis on preventive care and improved recovery outcomes has also encouraged healthcare providers to adopt innovative products, thereby driving the artificial tendon and ligaments market growth.

Artificial Tendon and Ligaments Market Report Highlights

By application, in 2024, the knee injuries segment accounted for the largest market share, primarily due to the increasing incidence of anterior cruciate ligament (ACL) injuries.

Based on end use, in 2024, the hospitals segment dominated the artificial tendons and ligaments market due to the increasing number of tendon repairs performed in hospitals.

In 2024, Europe dominated the artificial tendon and ligaments market due to the presence of advanced healthcare infrastructure and a high standard of medical services that promote the adoption of innovative treatment options.

Asia Pacific is projected to be the fastest-growing market for artificial tendons and ligaments during the forecast period due to rapid urbanization and increasing disposable incomes, which boost sports participation, consequently increasing the incidence of sports-related injuries.

A few global key market players are COUSIN SURGERY, Smith+Nephew, Zimmer Biomet, Xiros Ltd. (Neoligaments), Orthomed, Shanghai PINE&POWER Biotech, Arthrex Inc., Corin Group, Enovis Corporation (Mathys AG Bettlach), Stryker, and GROUP FH ORTHO.

Polaris Market Research has segmented the artificial tendon and ligaments market report on the basis of application, end use, and region:

By Application Outlook (Revenue, USD Million, 2020-2034)

  • Knee Injuries
  • Shoulder Injuries
  • Foot & Ankle Injuries
  • Other Applications

By End Use Outlook (Revenue, USD Million, 2020-2034)

  • Hospitals
  • Outpatient Facilities

By Regional Outlook (Revenue, USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Artificial Tendon and Ligaments Market Insights

  • 4.1. Artificial Tendon and Ligaments Market - Market Snapshot
  • 4.2. Artificial Tendon and Ligaments Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidents of Sports Related Injuries
      • 4.2.1.2. Patients Preference for Advanced Treatment Options
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Procedure Costs and Unfavourable Reimbursement Scenario Across Major Markets
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Artificial Tendon and Ligaments Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Artificial Tendon and Ligaments Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
  • 5.3. Knee Injuries
    • 5.3.1. Artificial Tendon and Ligaments Market, by Knee Injuries, by Region, 2020-2034 (USD million)
  • 5.4. Shoulder Injuries
    • 5.4.1. Artificial Tendon and Ligaments Market, by Shoulder Injuries, by Region, 2020-2034 (USD million)
  • 5.5. Foot & Ankle Injuries
    • 5.5.1. Artificial Tendon and Ligaments Market, by Foot & Ankle Injuries, by Region, 2020-2034 (USD million)
  • 5.6. Other Applications
    • 5.6.1. Artificial Tendon and Ligaments Market, by Other Applications, by Region, 2020-2034 (USD million)

6. Artificial Tendon and Ligaments Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
  • 6.3. Hospitals
    • 6.3.1. Artificial Tendon and Ligaments Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 6.4. Outpatient Facilities
    • 6.4.1. Artificial Tendon and Ligaments Market, by Outpatient Facilities, by Region, 2020-2034 (USD million)

7. Artificial Tendon and Ligaments Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Artificial Tendon and Ligaments Market Assessment, By Geography, 2020-2034 (USD million)
  • 7.3. Artificial Tendon and Ligaments Market - North America
    • 7.3.1. North America: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
    • 7.3.2. North America: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.3.3. Artificial Tendon and Ligaments Market - US
      • 7.3.3.1. US: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.3.3.2. US: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.3.4. Artificial Tendon and Ligaments Market - Canada
      • 7.3.4.1. Canada: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.3.4.2. Canada: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
  • 7.4. Artificial Tendon and Ligaments Market - Europe
    • 7.4.1. Europe: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
    • 7.4.2. Europe: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.3. Artificial Tendon and Ligaments Market - UK
      • 7.4.3.1. UK: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.3.2. UK: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.4. Artificial Tendon and Ligaments Market - France
      • 7.4.4.1. France: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.4.2. France: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.5. Artificial Tendon and Ligaments Market - Germany
      • 7.4.5.1. Germany: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.5.2. Germany: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.6. Artificial Tendon and Ligaments Market - Italy
      • 7.4.6.1. Italy: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.6.2. Italy: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.7. Artificial Tendon and Ligaments Market - Spain
      • 7.4.7.1. Spain: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.7.2. Spain: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.8. Artificial Tendon and Ligaments Market - Netherlands
      • 7.4.8.1. Netherlands: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.8.2. Netherlands: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.9. Artificial Tendon and Ligaments Market - Russia
      • 7.4.9.1. Russia: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.9.2. Russia: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.4.10. Artificial Tendon and Ligaments Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.4.10.2. Rest of Europe: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
  • 7.5. Artificial Tendon and Ligaments Market - Asia Pacific
    • 7.5.1. Asia Pacific: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
    • 7.5.2. Asia Pacific: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.3. Artificial Tendon and Ligaments Market - China
      • 7.5.3.1. China: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.3.2. China: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.4. Artificial Tendon and Ligaments Market - India
      • 7.5.4.1. India: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.4.2. India: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.5. Artificial Tendon and Ligaments Market - Malaysia
      • 7.5.5.1. Malaysia: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.5.2. Malaysia: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.6. Artificial Tendon and Ligaments Market - Japan
      • 7.5.6.1. Japan: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.6.2. Japan: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.7. Artificial Tendon and Ligaments Market - Indonesia
      • 7.5.7.1. Indonesia: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.7.2. Indonesia: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.8. Artificial Tendon and Ligaments Market - South Korea
      • 7.5.8.1. South Korea: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.8.2. South Korea: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.9. Artificial Tendon and Ligaments Market - Australia
      • 7.5.9.1. Australia: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.9.2. Australia: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.5.10. Artificial Tendon and Ligaments Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.5.10.2. Rest of Asia Pacific: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
  • 7.6. Artificial Tendon and Ligaments Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
    • 7.6.2. Middle East & Africa: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.6.3. Artificial Tendon and Ligaments Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.6.3.2. Saudi Arabia: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.6.4. Artificial Tendon and Ligaments Market - UAE
      • 7.6.4.1. UAE: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.6.4.2. UAE: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.6.5. Artificial Tendon and Ligaments Market - Israel
      • 7.6.5.1. Israel: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.6.5.2. Israel: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.6.6. Artificial Tendon and Ligaments Market - South Africa
      • 7.6.6.1. South Africa: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.6.6.2. South Africa: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.6.7. Artificial Tendon and Ligaments Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.6.7.2. Rest of Middle East & Africa: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
  • 7.7. Artificial Tendon and Ligaments Market - Latin America
    • 7.7.1. Latin America: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
    • 7.7.2. Latin America: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.7.3. Artificial Tendon and Ligaments Market - Mexico
      • 7.7.3.1. Mexico: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.7.3.2. Mexico: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.7.4. Artificial Tendon and Ligaments Market - Brazil
      • 7.7.4.1. Brazil: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.7.4.2. Brazil: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.7.5. Artificial Tendon and Ligaments Market - Argentina
      • 7.7.5.1. Argentina: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.7.5.2. Argentina: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)
    • 7.7.6. Artificial Tendon and Ligaments Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Artificial Tendon and Ligaments Market, by Application, 2020-2034 (USD million)
      • 7.7.6.2. Rest of Latin America: Artificial Tendon and Ligaments Market, by End Use, 2020-2034 (USD million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Arthrex Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Corin Group
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. COUSIN SURGERY
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Enovis Corporation (Mathys AG Bettlach)
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. GROUP FH ORTHO
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Orthomed
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Shanghai PINE&POWER Biotech
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. SMITH+NEPHEW
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Stryker
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Xiros Ltd. (Neoligaments)
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. ZIMMER BIOMET
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦